Navigation Links
Mindray Announces Third Quarter 2009 Financial Results
Date:11/9/2009

ctual property rights and not infringe on the intellectual property rights of others; competition in the medical device industry in China and internationally; and general economic and business conditions in the countries in which we operate. The financial information contained in this release should be read in conjunction with the consolidated financial statements and notes thereto included in our public filings with the Securities and Exchange Commission. For a discussion of other important factors that could adversely affect our business, financial condition, results of operations and prospects, see "Risk Factors" beginning on page 5 of our annual report on Form 20-F, filed on May 8, 2009. Our results of operations for the third quarter of 2009 and for fiscal year 2009 are not necessarily indicative of our operating results for any future periods. Any projections in this release are based on limited information currently available to us, which is subject to change. Although such projections and the factors influencing them will likely change, we will not necessarily update the information. Such information speaks only as of the date of this release.

All references to "shares" are to our ordinary shares, which are divided into two classes, Class A and Class B. Each of our American Depositary Shares, which trade on the New York Stock Exchange, represents one Class A ordinary share.

About Mindray

We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets. From our main manufacturing and engineering base in China and through our worldwide distribution network, we are able to supply internationally a broad range of products across three primary business segments, comprised of patient monitoring and life support products, in-vitro diagnostic products
'/>"/>

SOURCE Mindray Medical International Limited
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine news :

1. Mindray Selects Actel Low-Power Flash FPGAs for Demanding Medical Equipment Applications
2. Mindray to Report Third Quarter 2007 Financial Results on November 1, 2007
3. Mindray to Attend 2007 RSNA Conference in Chicago
4. Mindray to Attend 2008 CLSA Asia Investors Forum
5. Mindray to Exhibit at 2008 European Congress of Radiology Annual Meeting
6. Mindray to Report Fourth Quarter and Fiscal Year 2007 Financial Results on March 5, 2008
7. Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results
8. Mindray to Attend the 11th Credit Suisse Asian Investment Conference
9. Mindrays Laptop-size M5 and BS-200 Receive FDA Clearance
10. Mindray to Attend the JPMorgan 4th Annual China Conference
11. Mindray to Exhibit at 2008 China International Medical Equipment Fair

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...25/PRNewswire/--Thanksgivingmealswillbedeliveredto...BeachareathankstoFaithInAction/VolunteerActionforA...visionofSCANHealthPlan.Formorethan17yearstheseorga...warmThanksgivingmealstoseniorsinneedinLongBeach,La...undingcities. ,, "Ourwarmholidaymealsaredeliver...
(Date:11/25/2009)...ewswire-USNewswire/--TheBlackAIDSInstituterecently...adershipfor2010. ,, ThenewBoardMembersareahighl...y,law,finance,governmenthealthprograms,editorial,a...iderangeofpersonalbackgroundsincludingbothheterose...lves,andrepresentingmultipleagegroups. ,, (Phot...
(Date:11/25/2009)...ements,Business,andPressJoinEfforttoEducate ,,...again,theNationalBipolarFoundationandtheMedicAlert...tilStable"program,whichisnowbeingwidelyacceptedasa...y,theNationalBipolarFoundationreceivedaproclamatio...Lt.GovernorofLouisianaMitchLandrieu.TheNationalBip...
(Date:11/25/2009)...ence of a statistically significant survival benef...trogen receptor (ER)-positive tumors had high leve...ER-alpha S118-P), according to a brief communicati... the National Cancer Institute . , Approximately...en. Preclinical studies have shown that ER-alpha S...
(Date:11/25/2009)...pressure? This simple question has been the focus...elated gene Modulates High Blood Pressure in Mice ... simple question has been the focus of intense res...e first time established a link between a novel ge...stress in mice as well as humans. The studies were...
Breaking Medicine News(10 mins):Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:New stress-related gene modulates high blood pressure in mice and men 2
...e 13 /PRNewswire-FirstCall/ - Haemacure Corporatio...apeutics company developing,high-value human plasm...nnounced today that Joseph Galli, Chairman and Chi... Global Event for,Biotechnology. The presentation ...
...in England have had a piercing somewhere other tha...lications, and one in 100 piercings resulting in a...d on bmj.com today. , The study, carried out by... more likely than men to have a body piercing and ...
...Petty Urges Men Over 50 To Take "Kyle Petty,s ...OOKLYN, Mich., June 13 Car racing runs in,the Pet...s son Richard and,grandson Kyle. But like too many...to include a medical,oncologist, NASCAR champion K...
...g Medical Solutions, Inc.,(Rising), a leading medi...o,announce that they have chosen Bank of America a... client-facing treasury management offerings., (L...he foundation for the Company,s medical Provider p...
... activated anxiety-relieving genes, rat research s...-- Just sniffing that first hot cup of coffee in t...e feeling, a South Korean trial indicates. , When ...vity, the researchers reported. , "The meaning of...
...traffic-related pollution for increasing the risk ...ore than fifty percent. What,s more, the closer ch...Children] living very close to a major road are li...xic," wrote lead author of the research, Joachim H...
Other Medicine News:Health News:1 in 10 adults has a non-earlobe piercing 2Health News:New STAY ON TRACK for Better Prostate Health Program Launches Father's Day Weekend at NASCAR Race 2Health News:New STAY ON TRACK for Better Prostate Health Program Launches Father's Day Weekend at NASCAR Race 3Health News:New STAY ON TRACK for Better Prostate Health Program Launches Father's Day Weekend at NASCAR Race 4Health News:Rising Medical Solutions Chooses Bank of America to Bring Enhanced Cash Management and Provider Payment Solutions to the Marketplace 2Health News:Rising Medical Solutions Chooses Bank of America to Bring Enhanced Cash Management and Provider Payment Solutions to the Marketplace 3Health News:Coffee Beans May Be Newest Stress-Buster 2Health News:Coffee Beans May Be Newest Stress-Buster 3Health News:Road pollution blamed for higher allergy risk in kids 2
(Date:11/25/2009)...RIDGEWATER,N.J.,Nov.25/PRNewswire/--TheFDAgrantedt...blets,anon-nucleosidereversetranscriptaseinhibitor...edforuseintreatment-experiencedadultswhoareexperie...NNRTIandotherantiretroviral(ARV)agents.Thetraditio...sknownasDUET-1andDUET-2.INTELENCEiscurrentlymarket...
(Date:11/25/2009)...ASKINGRIDGE,N.J.,Nov.25/PRNewswire/--RegadoBioscie...ntithromboticaptamerswithactivecontrolagents,annou...ntingatthePiperJaffray21stAnnualHealthCareConferen...resentationwillbegivenat1:10pm(EST)onTuesday,Decem...withemphasisontheleaddevelopmentprogram,theanticoa...
(Date:11/25/2009)...NIONCITY,Calif.,Nov.25/PRNewswire-FirstCall/--Abax...facturingpoint-of-carebloodanalysissystems,announc...officer,willpresentatthe21stAnnualPiperJaffrayHeal...m.ET.TheconferencewillbeheldattheNewYorkPalaceHote...velops,manufacturesandmarketsportablebloodanalysis...
Breaking Medicine Technology:U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2A WIT Technologies Releases World 26apos 3Bs First Low Cost C Stamp 28TM 29 Based Biotechnology Laboratory in a Box 12572 1A WIT Technologies Releases World 26apos 3Bs First Low Cost C Stamp 28TM 29 Based Biotechnology Laboratory in a Box 12572 2Polycom and AMD Global Telemedicine Inc To Deliver Integrated Visual And Voice Telehealth Capability To Clinicians On The Go 48554 1Polycom and AMD Global Telemedicine Inc To Deliver Integrated Visual And Voice Telehealth Capability To Clinicians On The Go 48554 2Polycom and AMD Global Telemedicine Inc To Deliver Integrated Visual And Voice Telehealth Capability To Clinicians On The Go 48554 3Want to Learn How to Testify 3F New Home Study Course by Practicing Physician Teaches Medical Malpractice Defendants and Physicians How to be Effectiv 48551 1Want to Learn How to Testify 3F New Home Study Course by Practicing Physician Teaches Medical Malpractice Defendants and Physicians How to be Effectiv 48551 2Want to Learn How to Testify 3F New Home Study Course by Practicing Physician Teaches Medical Malpractice Defendants and Physicians How to be Effectiv 48551 3
...6 D-Pharm announced today that it,has submitted I...to the US,Food and Drug Administration (FDA), for ...acute ischemic stroke patients. D-Pharm plans to i...view of the IND and SPA. Recently,D-Pharm also obt...s Agency,(EMEA) on the development strategy for DP...
...ikely to Suffer from Lower Body Injuries , , CINC..., obese children are significantly more likely to ...and legs. The Cincinnati Children,s Hospital Medic...if different body parts are injured in obese child...ion strategies can be developed, was presented May...
Other Medicine Technology:D-Pharm Submits Investigational New Drug Application and Special Protocol Assessment to the FDA for Phase III Trial of DP-b99 in Acute Stroke Patients 2D-Pharm Submits Investigational New Drug Application and Special Protocol Assessment to the FDA for Phase III Trial of DP-b99 in Acute Stroke Patients 3The Injured Obese Child: Let's Give Him Some Ankle Support 2The Injured Obese Child: Let's Give Him Some Ankle Support 3
...ctious disease ELISA products make us a leader in ...er integration into the busy laboratory, our Infec...iability and run-to-run consistency. Our Infectiou...ssays for a wide range of serological assays inclu...
...ctious disease ELISA products make us a leader in ...er integration into the busy laboratory, our Infec...iability and run-to-run consistency. Our Infectiou...ssays for a wide range of serological assays inclu...
...ctious disease ELISA products make us a leader in ...er integration into the busy laboratory, our Infec...iability and run-to-run consistency. Our Infectiou...ssays for a wide range of serological assays inclu...
...ctious disease ELISA products make us a leader in ...er integration into the busy laboratory, our Infec...iability and run-to-run consistency. Our Infectiou...ssays for a wide range of serological assays inclu...
Medicine Products: